BioXcel Therapeutics, Inc. (BTAI)
BTAI has a market cap or net worth of $550.24 million. The enterprise value is $480.49 million.
The last earnings date was Monday, May 8, 2023, before market open.
|Earnings Date||May 8, 2023|
BTAI has 29.16 million shares outstanding. The number of shares has increased by 2.27% in one year.
|Shares Change (YoY)||+2.27%|
|Shares Change (QoQ)||+1.95%|
|Owned by Insiders (%)||31.26%|
|Owned by Institutions (%)||53.56%|
|EV / Earnings||n/a|
|EV / Sales||827.00|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 6.16, with a Debt / Equity ratio of 1.81.
|Debt / Equity||1.81|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
Return on equity (ROE) is -177.70% and return on invested capital (ROIC) is -239.20%.
|Return on Equity (ROE)||-177.70%|
|Return on Assets (ROA)||-85.10%|
|Return on Capital (ROIC)||-239.20%|
|Revenue Per Employee||$3,175|
|Profits Per Employee||-$1.02M|
|Effective Tax Rate||n/a|
Stock Price Statistics
The stock price has increased by +63.52% in the last 52 weeks. The beta is 1.11, so BTAI's price volatility has been higher than the market average.
|52-Week Price Change||+63.52%|
|50-Day Moving Average||21.46|
|200-Day Moving Average||19.82|
|Average Volume (30 Days)||560,215|
Short Selling Information
The latest short interest is 3.35 million, so 11.47% of the outstanding shares have been sold short.
|Short Previous Month||3.54M|
|Short % of Shares Out||11.47%|
|Short % of Float||18.35%|
|Short Ratio (days to cover)||7.50|
In the last 12 months, BTAI had revenue of $581,000 and -$187.08 million in losses. Loss per share was -$6.64.
|Loss Per Share||-$6.64|
The company has $165.52 million in cash and $95.77 million in debt, giving a net cash position of $69.76 million or $2.39 per share.
|Cash & Cash Equivalents||165.52M|
|Net Cash Per Share||$2.39|
|Equity / Book Value||53.01M|
|Book Value Per Share||1.82|
In the last 12 months, operating cash flow was -$155.28 million and capital expenditures -$19,000, giving a free cash flow of -$155.30 million.
|Operating Cash Flow||-155.28M|
|Free Cash Flow||-155.30M|
|FCF Per Share||-$5.43|
Gross margin is 95.01%, with operating and profit margins of -30,872.63% and -32,199.48%.
Dividends & Yields
BTAI does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
The average price target for BTAI is $45.83, which is 142.87% higher than the current price. The consensus rating is "Strong Buy".
|Price Target Difference||142.87%|
|Analyst Consensus||Strong Buy|
|Revenue Growth Forecast (5Y)||329.26%|
|EPS Growth Forecast (5Y)||n/a|
This stock does not have any record of stock splits.
|Last Split Date||n/a|